The Significance of Neuroinflammation in Understanding Alzheimer's Disease

Overview

Journal J Neural Transm (Vienna)

Specialties Neurology
Physiology

Date 2006 Oct 13

PMID 17036175

Citations 101

Authors

P Eikelenboom

R Veerhuis

W Scheper

A J M Rozemuller

W A van Gool

J J M Hoozemans

Affiliations

Soon will be listed here.

Abstract

The interest of scientists in the involvement of inflammation-related mechanisms in the pathogenesis of Alzheimer's disease (AD) goes back to the work of one of the pioneers of the study of this disease. About hundred years ago Oskar Fischer stated that the crucial step in the plaque formation is the extracellular deposition of a foreign substance that provokes an inflammatory reaction followed by a regenerative response of the surrounding nerve fibers. Eighty years later immunohistochemical studies revealed that amyloid plaques are indeed co-localized with a broad variety of inflammation-related proteins (complement factors, acute-phase proteins, pro-inflammatory cytokines) and clusters of activated microglia. These findings have led to the view that the amyloid plaque is the nidus of a non-immune mediated chronic inflammatory response locally induced by fibrillar A beta deposits. Recent neuropathological studies show a close relationship between fibrillar A beta deposits, inflammation and neuroregeneration in relatively early stages of AD pathology preceding late AD stages characterized by extensive tau-related neurofibrillary changes. In the present work we will review the role of inflammation in the early stage of AD pathology and particularly the role of inflammation in A beta metabolism and deposition. We also discuss the possibilities of inflammation-based therapeutic strategies in AD.

Citing Articles

Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity.

Navakkode S, Kennedy B Front Aging Neurosci. 2024; 16:1428244.

PMID: 39161341 PMC: 11330810. DOI: 10.3389/fnagi.2024.1428244.

TRP channels: Role in neurodegenerative diseases and therapeutic targets.

Rather M, Khan A, Wang L, Jahan S, Rehman M, Makeen H Heliyon. 2023; 9(6):e16910.

PMID: 37332910 PMC: 10272313. DOI: 10.1016/j.heliyon.2023.e16910.

Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer's Disease.

Rani S, Dhar S, Khajuria A, Gupta D, Jaiswal P, Singla N Cell Mol Neurobiol. 2023; 43(6):2491-2523.

PMID: 36847930 PMC: 11410160. DOI: 10.1007/s10571-023-01330-y.

Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging.

Reale M, Costantini E, Aielli L, Di Giuseppe F, Angelucci S, Kamal M Int J Mol Sci. 2022; 23(23).

PMID: 36499421 PMC: 9740614. DOI: 10.3390/ijms232315097.

Near-Infrared Photothermally Enhanced Photo-Oxygenation for Inhibition of Amyloid-β Aggregation Based on RVG-Conjugated Porphyrinic Metal-Organic Framework and Indocyanine Green Nanoplatform.

Wang J, Gu Y, Liu X, Fan Y, Zhang Y, Yi C Int J Mol Sci. 2022; 23(18).

PMID: 36142796 PMC: 9505608. DOI: 10.3390/ijms231810885.

References

Koo E, Park L, Selkoe D . Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc Natl Acad Sci U S A. 1993; 90(10):4748-52. PMC: 46590. DOI: 10.1073/pnas.90.10.4748. View

Hoozemans J, Veerhuis R, Rozemuller J, Eikelenboom P . Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology. Int J Dev Neurosci. 2005; 24(2-3):157-65. DOI: 10.1016/j.ijdevneu.2005.11.001. View

Riley K, Snowdon D, Markesbery W . Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 2002; 51(5):567-77. DOI: 10.1002/ana.10161. View

Shaffer L, Dority M, Frederickson R, Younkin S, Brunden K . Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging. 1995; 16(5):737-45. DOI: 10.1016/0197-4580(95)00055-j. View

Geddes J, Monaghan D, Cotman C, Lott I, Kim R, Chui H . Plasticity of hippocampal circuitry in Alzheimer's disease. Science. 1985; 230(4730):1179-81. DOI: 10.1126/science.4071042. View

Hoozemans J, Veerhuis R, van Haastert E, Rozemuller J, Baas F, Eikelenboom P . The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 2005; 110(2):165-72. DOI: 10.1007/s00401-005-1038-0. View

Breen K . APP-collagen interaction is mediated by a heparin bridge mechanism. Mol Chem Neuropathol. 1992; 16(1-2):109-21. DOI: 10.1007/BF03159964. View

Beher D, Clarke E, Wrigley J, Martin A, Nadin A, Churcher I . Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism. J Biol Chem. 2004; 279(42):43419-26. DOI: 10.1074/jbc.M404937200. View

Griffin W, Stanley L, Ling C, White L, MacLeod V, Perrot L . Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A. 1989; 86(19):7611-5. PMC: 298116. DOI: 10.1073/pnas.86.19.7611. View

10.

Arends Y, Duyckaerts C, Rozemuller J, Eikelenboom P, Hauw J . Microglia, amyloid and dementia in alzheimer disease. A correlative study. Neurobiol Aging. 2000; 21(1):39-47. DOI: 10.1016/s0197-4580(00)00094-4. View

11.

Iwata N, Higuchi M, Saido T . Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol Ther. 2005; 108(2):129-48. DOI: 10.1016/j.pharmthera.2005.03.010. View

12.

Arendt T . Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience. 2001; 102(4):723-65. DOI: 10.1016/s0306-4522(00)00516-9. View

13.

Bales K, Verina T, Dodel R, Du Y, Altstiel L, Bender M . Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat Genet. 1997; 17(3):263-4. DOI: 10.1038/ng1197-263. View

14.

Vehmas A, Kawas C, Stewart W, Troncoso J . Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging. 2002; 24(2):321-31. DOI: 10.1016/s0197-4580(02)00090-8. View

15.

Williams A, van Dam A, Ritchie D, Eikelenboom P, Fraser H . Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 1997; 754(1-2):171-80. DOI: 10.1016/s0006-8993(97)00067-x. View

16.

Bateman R, Munsell L, Morris J, Swarm R, Yarasheski K, Holtzman D . Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat Med. 2006; 12(7):856-61. PMC: 2983090. DOI: 10.1038/nm1438. View

17.

Narindrasorasak S, Lowery D, Altman R, Greenberg B, Kisilevsky R . Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab Invest. 1992; 67(5):643-52. View

18.

Hoozemans J, van Haastert E, Veerhuis R, Arendt T, Scheper W, Eikelenboom P . Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation. 2005; 2:27. PMC: 1308853. DOI: 10.1186/1742-2094-2-27. View

19.

Itagaki S, McGeer P, Akiyama H, Zhu S, Selkoe D . Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 1989; 24(3):173-82. DOI: 10.1016/0165-5728(89)90115-x. View

20.

Yaffe K, Lindquist K, Penninx B, Simonsick E, Pahor M, Kritchevsky S . Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology. 2003; 61(1):76-80. DOI: 10.1212/01.wnl.0000073620.42047.d7. View